BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

345 related articles for article (PubMed ID: 25511568)

  • 1. Cytotoxicity of curcumin silica nanoparticle complexes conjugated with hyaluronic acid on colon cancer cells.
    Singh SP; Sharma M; Gupta PK
    Int J Biol Macromol; 2015 Mar; 74():162-70. PubMed ID: 25511568
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hyaluronic acid-tagged silica nanoparticles in colon cancer therapy: therapeutic efficacy evaluation.
    Liu K; Wang ZQ; Wang SJ; Liu P; Qin YH; Ma Y; Li XC; Huo ZJ
    Int J Nanomedicine; 2015; 10():6445-54. PubMed ID: 26491300
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced drug loading on magnetic nanoparticles by layer-by-layer assembly using drug conjugates: blood compatibility evaluation and targeted drug delivery in cancer cells.
    Manju S; Sreenivasan K
    Langmuir; 2011 Dec; 27(23):14489-96. PubMed ID: 21988497
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gold nanoparticles generated and stabilized by water soluble curcumin-polymer conjugate: blood compatibility evaluation and targeted drug delivery onto cancer cells.
    Manju S; Sreenivasan K
    J Colloid Interface Sci; 2012 Feb; 368(1):144-51. PubMed ID: 22200330
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyaluronic acid/chitosan nanoparticles for delivery of curcuminoid and its in vitro evaluation in glioma cells.
    Yang L; Gao S; Asghar S; Liu G; Song J; Wang X; Ping Q; Zhang C; Xiao Y
    Int J Biol Macromol; 2015 Jan; 72():1391-401. PubMed ID: 25450553
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The eradication of breast cancer cells and stem cells by 8-hydroxyquinoline-loaded hyaluronan modified mesoporous silica nanoparticle-supported lipid bilayers containing docetaxel.
    Wang D; Huang J; Wang X; Yu Y; Zhang H; Chen Y; Liu J; Sun Z; Zou H; Sun D; Zhou G; Zhang G; Lu Y; Zhong Y
    Biomaterials; 2013 Oct; 34(31):7662-73. PubMed ID: 23859657
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Poly(D,L-lactic acid)-glycerol-based nanoparticles for curcumin delivery.
    Yoon IS; Park JH; Kang HJ; Choe JH; Goh MS; Kim DD; Cho HJ
    Int J Pharm; 2015 Jul; 488(1-2):70-7. PubMed ID: 25900098
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Curcumin-loaded redox-responsive mesoporous silica nanoparticles for targeted breast cancer therapy.
    Li N; Wang Z; Zhang Y; Zhang K; Xie J; Liu Y; Li W; Feng N
    Artif Cells Nanomed Biotechnol; 2018; 46(sup2):921-935. PubMed ID: 29790797
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hyaluronic acid-functionalized polymeric nanoparticles for colon cancer-targeted combination chemotherapy.
    Xiao B; Han MK; Viennois E; Wang L; Zhang M; Si X; Merlin D
    Nanoscale; 2015 Nov; 7(42):17745-55. PubMed ID: 26455329
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyaluronic acid hydrophilic surface rehabilitating curcumin nanocrystals for targeted breast cancer treatment with prolonged biodistribution.
    Ji P; Wang L; Chen Y; Wang S; Wu Z; Qi X
    Biomater Sci; 2020 Jan; 8(1):462-472. PubMed ID: 31750450
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nanoparticles based on chitosan hydrochloride/hyaluronic acid/PEG containing curcumin: In vitro evaluation and pharmacokinetics in rats.
    Xu Y; Asghar S; Yang L; Chen Z; Li H; Shi W; Li Y; Shi Q; Ping Q; Xiao Y
    Int J Biol Macromol; 2017 Sep; 102():1083-1091. PubMed ID: 28472690
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    Huang C; Chen F; Zhang L; Yang Y; Yang X; Pan W
    Int J Nanomedicine; 2020; 15():2987-2998. PubMed ID: 32431497
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyaluronic acid modified mesoporous silica nanoparticles for targeted drug delivery to CD44-overexpressing cancer cells.
    Yu M; Jambhrunkar S; Thorn P; Chen J; Gu W; Yu C
    Nanoscale; 2013 Jan; 5(1):178-83. PubMed ID: 23076766
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Formulation of curcumin delivery with functionalized single-walled carbon nanotubes: characteristics and anticancer effects in vitro.
    Li H; Zhang N; Hao Y; Wang Y; Jia S; Zhang H; Zhang Y; Zhang Z
    Drug Deliv; 2014 Aug; 21(5):379-87. PubMed ID: 24160816
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dual targeting curcumin loaded alendronate-hyaluronan- octadecanoic acid micelles for improving osteosarcoma therapy.
    Xi Y; Jiang T; Yu Y; Yu J; Xue M; Xu N; Wen J; Wang W; He H; Shen Y; Chen D; Ye X; Webster TJ
    Int J Nanomedicine; 2019; 14():6425-6437. PubMed ID: 31496695
    [TBL] [Abstract][Full Text] [Related]  

  • 16. pH-responsive hyaluronic acid-based nanoparticles for targeted curcumin delivery and enhanced cancer therapy.
    Lai H; Ding X; Ye J; Deng J; Cui S
    Colloids Surf B Biointerfaces; 2021 Feb; 198():111455. PubMed ID: 33243547
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Co-delivery of etoposide and curcumin by lipid nanoparticulate drug delivery system for the treatment of gastric tumors.
    Jiang H; Geng D; Liu H; Li Z; Cao J
    Drug Deliv; 2016 Nov; 23(9):3665-3673. PubMed ID: 27749102
    [TBL] [Abstract][Full Text] [Related]  

  • 18. pH-sensitive micelles based on acid-labile pluronic F68-curcumin conjugates for improved tumor intracellular drug delivery.
    Fang XB; Zhang JM; Xie X; Liu D; He CW; Wan JB; Chen MW
    Int J Pharm; 2016 Apr; 502(1-2):28-37. PubMed ID: 26784981
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functionalizing the surface of hydroxyapatite drug carrier with carboxylic acid groups to modulate the loading and release of curcumin nanoparticles.
    Lee WH; Loo CY; Rohanizadeh R
    Mater Sci Eng C Mater Biol Appl; 2019 Jun; 99():929-939. PubMed ID: 30889767
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hyaluronic acid coating on the surface of curcumin-loaded ZIF-8 nanoparticles for improved breast cancer therapy: An in vitro and in vivo study.
    Yu S; Wang S; Xie Z; Yu S; Li L; Xiao H; Song Y
    Colloids Surf B Biointerfaces; 2021 Jul; 203():111759. PubMed ID: 33892283
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.